Twist Bioscience Corp Quarterly Net Income (Loss) Attributable to Parent in USD from Q4 2017 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Twist Bioscience Corp quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q4 2017 to Q2 2024.
  • Twist Bioscience Corp Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$85.6M, a 49.1% decline year-over-year.
  • Twist Bioscience Corp Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$220M, a 5.17% decline year-over-year.
  • Twist Bioscience Corp annual Net Income (Loss) Attributable to Parent for 2023 was -$205M, a 6.08% increase from 2022.
  • Twist Bioscience Corp annual Net Income (Loss) Attributable to Parent for 2022 was -$218M, a 43.2% decline from 2021.
  • Twist Bioscience Corp annual Net Income (Loss) Attributable to Parent for 2021 was -$152M, a 8.7% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$220M -$85.6M -$28.2M -49.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-02
Q1 2024 -$192M -$45.5M +$13.7M +23.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 -$206M -$43M -$1.18M -2.83% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-02
Q3 2023 -$205M -$46.2M +$4.87M +9.53% Jul 1, 2023 Sep 30, 2023 10-K 2023-11-21
Q2 2023 -$209M -$57.4M +$3.12M +5.16% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-02
Q1 2023 -$213M -$59.2M +$1.51M +2.49% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 -$214M -$41.8M +$3.74M +8.21% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-02
Q3 2022 -$218M -$51.1M -$9.87M -23.9% Jul 1, 2022 Sep 30, 2022 10-K 2023-11-21
Q2 2022 -$208M -$60.5M -$20.5M -51.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 -$188M -$60.7M -$22.7M -60% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 -$165M -$45.6M -$12.7M -38.5% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-07
Q3 2021 -$152M -$41.2M -$16.9M -69.6% Jul 1, 2021 Sep 30, 2021 10-K 2023-11-21
Q2 2021 -$135M -$40M -$11.8M -41.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$123M -$37.9M -$6.15M -19.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 -$117M -$32.9M +$22.7M +40.9% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-09
Q3 2020 -$140M -$24.3M +$6.86M +22% Jul 1, 2020 Sep 30, 2020 10-K/A 2023-06-05
Q2 2020 -$147M -$28.2M -$291K -1.04% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 -$147M -$31.8M -$5.84M -22.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 -$141M -$55.6M -$33M -146% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-09
Q3 2019 -$108M -$31.2M -$11.4M -57.5% Jul 1, 2019 Sep 30, 2019 10-K 2021-11-23
Q2 2019 -$96.3M -$27.9M -$10.3M -58.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 -$86M -$25.9M -$9.06M -53.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 -$76.9M -$22.6M -$5.7M -33.7% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-10
Q3 2018 -$71.2M -$19.8M Jul 1, 2018 Sep 30, 2018 10-K 2020-11-27
Q2 2018 -$17.6M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$16.9M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q4 2017 -$16.9M Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.